BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32646476)

  • 1. Clinical and economic outcomes evaluated in Lyme disease: a systematic review.
    Mattingly TJ; Shere-Wolfe K
    Parasit Vectors; 2020 Jul; 13(1):341. PubMed ID: 32646476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The economic burden of Lyme disease and the cost-effectiveness of Lyme disease interventions: A scoping review.
    Mac S; da Silva SR; Sander B
    PLoS One; 2019; 14(1):e0210280. PubMed ID: 30608986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic impact of Lyme disease.
    Zhang X; Meltzer MI; Peña CA; Hopkins AB; Wroth L; Fix AD
    Emerg Infect Dis; 2006 Apr; 12(4):653-60. PubMed ID: 16704815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating direct healthcare costs attributable to laboratory-confirmed Lyme disease in Ontario, Canada: A population-based matched cohort study using health administrative data.
    Shing E; Wang J; Khoo E; Evans GA; Moore S; Nelder MP; Patel SN; Russell C; Sider D; Sander B
    Zoonoses Public Health; 2019 Jun; 66(4):428-435. PubMed ID: 30665259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health care costs, utilization and patterns of care following Lyme disease.
    Adrion ER; Aucott J; Lemke KW; Weiner JP
    PLoS One; 2015; 10(2):e0116767. PubMed ID: 25650808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A systematic review on population-based indicators of the quality of care in formal and informal provider networks and their application in health economic evaluations].
    Seibert K; Stiefler S; Domhoff D; Wolf-Ostermann K; Peschke D
    Z Evid Fortbild Qual Gesundhwes; 2019 Aug; 144-145():7-23. PubMed ID: 31327735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lyme disease--what is the cost for Scotland?
    Joss AW; Davidson MM; Ho-Yen DO; Ludbrook A
    Public Health; 2003 Jul; 117(4):264-73. PubMed ID: 12966749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic evaluation of HIV pre-exposure prophylaxis strategies: protocol for a methodological systematic review and quantitative synthesis.
    Thavorn K; Kugathasan H; Tan DHS; Moqueet N; Baral SD; Skidmore B; MacFadden D; Simkin A; Mishra S
    Syst Rev; 2018 Mar; 7(1):47. PubMed ID: 29544530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of health economic evaluation in the implementation and improvement science fields-a systematic literature review.
    Roberts SLE; Healey A; Sevdalis N
    Implement Sci; 2019 Jul; 14(1):72. PubMed ID: 31307489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generalisability in economic evaluation studies in healthcare: a review and case studies.
    Sculpher MJ; Pang FS; Manca A; Drummond MF; Golder S; Urdahl H; Davies LM; Eastwood A
    Health Technol Assess; 2004 Dec; 8(49):iii-iv, 1-192. PubMed ID: 15544708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incorporation of future costs in health economic analysis publications: current situation and recommendations for the future.
    Gros B; Soto Álvarez J; Ángel Casado M
    Expert Rev Pharmacoecon Outcomes Res; 2015 Jun; 15(3):465-9. PubMed ID: 25737028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tobacco Cost of Illness Studies: A Systematic Review.
    Makate M; Whetton S; Tait RJ; Dey T; Scollo M; Banks E; Norman R; Pidd K; Roche AM; Allsop S
    Nicotine Tob Res; 2020 Apr; 22(4):458-465. PubMed ID: 30874290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CONCEPTUALIZATIONS OF THE SOCIETAL PERSPECTIVE WITHIN ECONOMIC EVALUATIONS: A SYSTEMATIC REVIEW.
    Drost RMWA; van der Putten IM; Ruwaard D; Evers SMAA; Paulus ATG
    Int J Technol Assess Health Care; 2017 Jan; 33(2):251-260. PubMed ID: 28641592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diverse approaches to the health economic evaluation of bariatric surgery: a comprehensive systematic review.
    Campbell JA; Venn A; Neil A; Hensher M; Sharman M; Palmer AJ
    Obes Rev; 2016 Sep; 17(9):850-94. PubMed ID: 27383557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determining if Telehealth Can Reduce Health System Costs: Scoping Review.
    Snoswell CL; Taylor ML; Comans TA; Smith AC; Gray LC; Caffery LJ
    J Med Internet Res; 2020 Oct; 22(10):e17298. PubMed ID: 33074157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The economic cost of preventable disease in Australia: a systematic review of estimates and methods.
    Crosland P; Ananthapavan J; Davison J; Lambert M; Carter R
    Aust N Z J Public Health; 2019 Oct; 43(5):484-495. PubMed ID: 31390112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Systematic Review of Economic Evaluations in Vascular Surgery.
    Javidan AP; Naji F; Li A; Wu A; Srivatsav V; Rapanos T; Harlock J
    Ann Vasc Surg; 2020 Aug; 67():511-520.e1. PubMed ID: 32234577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analyzing the cost-effectiveness of Lyme disease risk reduction approaches.
    Behler RP; Sharareh N; Whetten JS; Sabounchi NS
    J Public Health Policy; 2020 Jun; 41(2):155-169. PubMed ID: 32015481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic Analysis of Formal Care, Informal Care, and Productivity Losses in Primary Care Patients who Screened Positive for Dementia in Germany.
    Michalowsky B; Thyrian JR; Eichler T; Hertel J; Wucherer D; Flessa S; Hoffmann W
    J Alzheimers Dis; 2016; 50(1):47-59. PubMed ID: 26639964
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.